Last reviewed · How we verify
Intranasal Oxytocin — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Intranasal Oxytocin (Intranasal Oxytocin) — Evdokia Anagnostou.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intranasal Oxytocin TARGET | Intranasal Oxytocin | Evdokia Anagnostou | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intranasal Oxytocin CI watch — RSS
- Intranasal Oxytocin CI watch — Atom
- Intranasal Oxytocin CI watch — JSON
- Intranasal Oxytocin alone — RSS
Cite this brief
Drug Landscape (2026). Intranasal Oxytocin — Competitive Intelligence Brief. https://druglandscape.com/ci/intranasal-oxytocin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab